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Abstract
N-Butylbenzene sulfonamide (NBBS) is a commonly used plasticizer found in numerous products. 
Due to its extensive use, lack of adequate toxicological data, and suspicion of toxicity based on the 
presence of structural alerts, it was nominated to the National Toxicology Program for 
comprehensive toxicological testing. The purpose of this study was to evaluate the potential for 
hypersensitivity and immune suppression following dermal exposure to NBBS using a murine 
model. NBBS tested negative in a combined irritancy/local lymph node assay (LLNA), classifying 
it as nonirritating and nonsensitizing. To estimate the immunosuppressive potential of NBBS, 
assays that assessed immunotoxicity were performed, including the immumnoglobulin (Ig) M 
response to T-cell-dependent antigen sheep red blood cells (SRBC), using the plaque-forming cell 
(PFC) assay and immune cell phenotyping. After a 28-d treatment with NBBS, mice exposed to 
the lowest concentration (25% NBBS) showed a significant increase in IgM-producing B cells in 
the spleen. No marked changes were identified in immune cell markers in the lymph node. In 
contrast to body weight, a significant elevation in kidney and liver weight was observed following 
dermal exposure to all concentrations of NBBS. These results demonstrate that dermal exposure to 
NBBS, other than liver and kidney toxicity, did not apparently induce immunotoxicity in a murine 
model.
N-Butylbenzenesulfonamide (NBBS) is a common plasticizer used in polyacetals, 
polycarbonates, polysulfones, and polyamides, in flexible tubing, and in the production of 
films, transparent coating, and plastic resins (Kumar et al. 2007; Strong et al. 1991). NBBS 
(1) enables easier machining and removal of plastics from molds, (2) produces a better 
finish, and (3) imparts heat stability (Proviron Fine Chemicals 2003). In addition to its 
plasticizer properties, NBBS possesses antifungal properties (Kim et al. 2000), and was 
described as a starting reagent for synthesis of a proposed sulfonyl carbamate herbicide as 
well as other industrial chemicals and drugs (Stephens 1976). In the United States alone, 
production volumes of NBBS in 2006 ranged from 1,000,000 to <10,000,000 lb, according 
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to the 2006 Inventory Reporting database. Environmental studies showed that NBBS is a 
groundwater contaminant and not readily biodegradable. NBBS was detected in pre- and 
posttertiary treatment water samples taken at a water treatment plant in southern California 
and ranged from approximately 1 to 16.3 μg/L (Soliman et al. 2007). Its presence was also 
demonstrated in different locations within the San Francisco Estuary (1999 and 2000) and in 
the Santa Ana River (2002) from variou sources including atmospheric deposition, sewage 
treatment plant and industrial wastewater effluent discharge, boating activities, and 
agricultural and urban runoff, ranging from 111 to 454 ng/L (Oros et al. 2003). In addition, 
NBBS was also identified in the effluents of doue major treatment plants that discharge into 
the Santa Ana River (concentration from 0 to 94 ng/L, <0.5 mg/L) (Gross et al. 2004). In 
Europe in 2001, NBBS was detected in eight locations in the Rhine River (92 to 190 ng/L), 
which flows through highly industrialized areas in Switzerland, Germany and the 
Netherlands and is an important reservoir of drinking water (Schwarzbauer and Heim 2005).
Due to its widespread production and use, there may be significant potential for human 
exposure to NBBS, through ingestion, inhalation, and cutaneous routes. Oral exposure is 
possible due to its presence in contaminated water sources or due to potential leaching from 
consumer products (Skjevrak et al. 2005). However, inhalation and dermal exposure are the 
most common forms of occupational exposure that occur in rubber and plastic industries and 
all other chemical product and preparation manufacturing (U.S. EPA 2010b). The National 
Institute for Occupational Safety and Health (NIOSH) National Occupational Hazards 
Survey (1981–1983) estimated that 1534 employees (1169 female and 365 male) were 
potentially exposed to NBBS (NIOSH n.d.).
In spite of the large production volume and high exposure potential, there are insufficient 
toxicological data to adequately characterize potential human health risks to NBBS. As a 
result, NBBS was nominated to the National Toxicology Program (NTP) for comprehensive 
toxicological testing and evaluation. Results from limited animal studies suggest that this 
chemical may induce developmental, reproductive, and/or neurotoxic effects. In studies 
evaluating reproductive effects, NBBS was administered by oral gavage at 100, 200, or 400 
mg/kg to male and female Wistar rats 2 wk prior to mating. Males were dosed for a 
minimum of 28 d, while females were administered until postpartum day 3. At the high 
dose, adverse effects noted in parental animals included abnormal gait, tremors, hunched 
posture, piloerection, lethargy, and significant decreases in body weight, while low-dose 
females showed significant increases in body weight during the premating period. 
Reproductive performance was impaired in 9 of 12 high-dose mating pairs. A significant 
reduction in absolute testis and epididymides weight was observed in high-dose males. 
Histopathological evaluation of the testes and epididymides noted several effects, including 
Sertoli cell vacuolation, spermatid retention, multinucleated giant cells, desquamation of 
germ cells, absence of spermatids, atrophy of testis, and oligospermia. An elevated rate of 
offspring loss (pre- and postimplantation, and postpartum) was found for high-dose female 
rats, and mean pup weight was decreased (IUCLID 2007). In another study, pregnant mice 
were administered NBBS (500 or 750 mg/kg/d) via intraperitoneal (ip) injection and 
examined on gestation day 13. The number of live fetuses, average crown–rump lengths, 
body weight, and placental weight in both treatment groups were significantly reduced 
compared to control dams (Hashimoto et al. 1991).
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In vitro studies support a role for NBBS cytotoxicity in Neuro-2a and C6 glioma cells. 
Following a 72-h incubation using conventional assays for cell viability and function, 
micromolar concentrations of NBBS inhibited cell growth, produced morphological 
changes, and altered cell function in these cell lines. A lower concentration of NBBS was 
required to inhibit DNA synthesis in Neuro-2a cells (10 pM) than in C6 glioma cells (100 
pM), suggesting that neuronal cells may be more sensitive than glial cells to NBBS-
mediated toxicity. The effects of NBBS on DNA synthesis in C6 glioma cells occurred as 
early as 24 h after exposure to a concentration of 10 pM as shown by an 18% inhibition of 
thymidine incorporation, with 30% inhibition at 72 h. At an NBBS concentration of 250 pM, 
DNA synthesis was markedly inhibited (70%) at 72 h. C6 glioma cells exposed to 100 or 
250 pM NBBS exhibited markedly reduced or absence of immunoreactivity with antibodies 
against glial fibrillary acidic protein and S-100 protein, while Neuro-2a cells incubated with 
1 or 10 pM NBBS demonstrated significantly less staining for the 160-kD neurofilament 
subunit protein (Nerurkar et al. 1993). NBBS (35–2000 μg/ml) also was found to be 
cytotoxic to human lymphocytes following exposure to 1000 or 2000 μg/mL (IUCLID 
2007).
Due to the high production volume of NBBS, high potential for human exposure, and lack of 
dermal toxicological data, this study was performed to evaluate the immunotoxicity 
following subchronic dermal exposure to NBBS in a murine model.
Materials and Methods
Animals
Female BALB/c and B6C3F1 mice were used in these studies. BALB/c mice have a T-
helper (Th2) bias and are commonly used to evaluate potential immunoglobulin (Ig) E-
mediated sensitization and therefore used in the hypersensitivity studies (Klink and Meade 
2003; Woolhiser et al. 2000). B6C3F1 mice are the strain of choice for immunotoxicity 
studies and were used to evaluate the IgM response to sheep red blood cells (SRBC) (Luster 
et al. 1992). All mice were purchased from Taconic Farms (Germantown, NY) at 5–9 wk of 
age weighing 18–20 g and allowed to acclimate for a minimum of 5 d before they were 
randomly assigned to treatment groups. Animals were weighed and individually identified 
via tail markings using a permanent marker. A preliminary analysis of variance on body 
weights was performed to ensure homogeneous distribution of animals across treatment 
groups. Animals were housed 5 per cage (except for concentration range-finding studies, 
which required mice to be housed 3 per cage) in ventilated plastic shoebox cages with 
hardwood chip bedding, fed NIH-31 modified 6% irradiated rodent diet (Harlan Teklad), 
and provided tap water from water bottles, ad libitum. The temperature in the animal facility 
was maintained between 18 and 73°C with relative humidity between 30 and 70%. The 
light/dark cycle was maintained on 12-h intervals. All animal experiments were performed 
in the Association for Assessment and Accreditation of Laboratory Animal Care 
(AAALAC)-accredited National Institute for Occupational Safety and Health animal facility 
in accordance with an animal protocol approved by the Institutional Animal Care and Use 
Committee.
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Chemicals
N-Butylbenzene sulfonamide (CAS number 3622-84-2; Figure 1), acetone vehicle (CAS 
number 67-64-1), USP grade phosphate-buffered saline (PBS), the positive control for the 
LLNA alpha-hexylcinnamaldehyde (HCA, CAS number 101-86-0), the irritancy control 2,4- 
dinitrofluorobenzene (DNFB, CAS number 70-34-8), and cyclophosphamide (CP) control 
for plaque-forming cell assay (PFC assay) (CP, CAS number 50-18-0) were purchased from 
Sigma Aldrich (St. Louis, MO).
Concentration Range-Finding Study
An initial range-finding study was conducted to determine the test article concentrations to 
be used in the subsequent studies. Mice (3 per group) were exposed topically on each ear to 
25 μl vehicle (acetone) or 100% NBBS for 3 consecutive days. Animals were allowed to rest 
for 2 d following the last exposure and then euthanized via CO2 inhalation. Mice were 
observed daily for signs of distress or extreme irritation, for any signs of chemical-induced 
toxicity (ruffled fur, abnormal posture, isolation in the cage, abnormal exudates from the 
eyes, nose, or anus), and for local signs of irritation, including ear erythema and swelling. 
Animals were weighed the day prior to the first exposure and on d 4 prior to euthanasia.
Combined Irritancy and Local Lymph Node Assay
To determine the irritancy and sensitization potential of NBBS, a combined irritancy/LLNA 
was conducted and performed according to the method described in the Interagency 
Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Peer Review 
Panel report (National Institute of Environmental Health Sciences [NIEHS] 1999) and as 
previously described (Anderson et al. 2013).
In Vivo IGM Response to the T-Cell-Dependent Antigen SRBC
The primary IgM response to sheep red blood cells (SRBC) was enumerated using a 
modified hemolytic plaque-forming cell (PFC) assay of Jerne and Nordin (1963). B6C3F1 
mice were exposed over a 28-d period dermally (25 μl per dorsal surface of each ear). This 
exposure schedule is based on immune-toxicity guidelines set forth by the NTP. Groups of 
mice (5/group) were exposed to one of three concentrations of test agents or acetone vehicle 
over a 28-d period for each mouse. Systemic toxicity was evaluated weekly by clinical 
observations and change in body weight. The PFC assay was conducted as previously 
described (Anderson et al. 2013). Results were expressed as specific activity (IgM PFC per 
106 spleen cells) and total activity (IgM PFC per spleen).
Immune Cell Phenotyping
Animals were euthanized by CO2 inhalation 24 h after the final exposure, weighed, and 
examined for gross pathology. Blood was collected in ethylenediamine tetraacetic acid 
(EDTA)-coated vacutainer tubes following transection of the abdominal aorta, and 
hematological analysis was conducted (see later description). The liver, spleen, kidneys, and 
thymus were removed, cleaned of connective tissue, and weighed. Spleen and DLN cell 
suspensions were prepared by mechanical disruption of tissues between frosted microscope 
slides in phosphate-buffered saline (PBS) and counted on a cellometer (Nexcelom). Cells 
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(1–2 × 106) were aliquoted into a 96-well U-bottom plate and washed in staining buffer 
(PBS + 1% bovine serum albumin + 0.1% sodium azide). Cells were resuspened in staining 
buffer containing anti-mouse CD16/32 antibody (clone 2.4G2) for blocking of Fc receptors 
(BD Biosciences). Cells were next resuspended in staining buffer containing a cocktail of 
fluorochrome-conjugated antibodies specific for cell surface antigens: CD45-
Allophycocyanin (clone 30-F11), CD3e-V500 (500A2), CD4-Allophycocyanin-H7 (GK1.5), 
CD8a-PE-CF594 (53-6.7), CD45R/B220-Alexa Fluor 700 (RA3-6B2), NK1.1-FITC 
(PK136) (BD Biosciences), CD11c-eFluor 450 (N418), and CD11b-PerCP-Cyanine5.5 
(M1/70) (eBioscience). Cells were washed in staining buffer and fixed in Cytofix buffer 
(BD Biosciences). Within 24 h, cells were resuspended in staining buffer and analyzed on an 
LSR II flow cytometer (BD Biosciences). Data analysis was performed with FlowJo 7.6.5 
software (TreeStar, Inc.). Leukocytes were first identified by their expression of CD45, and 
the cells were further identified as follows: CD4 T cells (CD4+ CD3+), CD8 T cells (CD8+ 
CD3+), B cells (B220+ CD3-), NK cells (NK1.1+, CD3-), and dendritic cells (CD11b+ 
CD11c+).
Hematology
Selected hematological parameters were evaluated using a Hemavet 950 automatic 
hematology analyzer (Drew Scientific, Waterbury, CT). Endpoints analyzed included 
peripheral erythrocyte and leukocyte counts, leukocyte differentials (lymphocytes, 
neutrophils, monocytes, basophils, and eosinophils), platelet counts, hematocrit, hemoglobin 
levels, mean corpuscular hemoglobin (MCH) and hemoglobin concentration (MCHC), mean 
corpuscular volume (MCP), mean platelet volume (MCV), and platelet distribution width 
(PDW).
Statistical Analysis
Data were first tested for homogeneity using the Bartlett's chi-squared test. If data were 
homogeneous, a one-way analysis of variance (ANOVA) was conducted. If ANOVA 
showed significance at p < .05 or less, Dunnett's multiple range t-test was used to compare 
treatment groups with the control group. For dose-response studies, linear trend analysis 
(linear trend test) was performed to determine whether NBBS had exposure concentration-
related effects for specific endpoints. Differences were considered to be significant if p < .05 
compared to vehicle controls. Statistical analysis was performed using Graph Pad Prism 
version 5.0 (San Diego, CA).
Results
In Vivo Studies
Dermal exposure of female BALB/c mice to the high concentration of NBBS (100%) 
produced no marked changes in body weight and there were no signs of overt toxicity or 
visual signs of inflammation at the exposure sites (data not shown). For this reason, 100% 
was selected as the highest test dose of NBBS, along with 50% and 25% (in acetone), to be 
used in subsequent investigations. A numerical increase in ear swelling was observed 
following exposure to NBBS (8.4, 7.2, and 5.6% for 25, 50, and 100% respectively) (Figure 
2A). DNFB (0.3%), used as a positive control for irritancy studies, showed a mean 
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significant rise of 241% ear swelling after exposure. While a dose-dependent elevation in 
lymphocyte proliferation was observed, it did not reach statistical significance. Exposure to 
25, 50, or 100% NBBS produced SI (stimulation index) values of 0.85, 1.9, and 2, 
respectively; therefore, an EC3 (threefold increase compared to vehicle control) value could 
not be calculated and NBBS was not considered to be sensitizing (Figure 2B). HCA (30%) 
was used as a positive control for the LLNA and resulted in an average SI value of 10.3 
(data not shown).
Dermal Exposure to NBBS for 28 d Results in Increased Liver and Kidney Weights
In contrast with body weight data, a significant increase in kidneys and liver weight was 
observed following exposure of female B6C3F1 mice to all concentrations of NBBS (Table 
1). The liver weight rose 28, 50, and 59%, and kidney weight increased 17, 19, and 
23%,following exposure to 25, 50, and 100% NBBS, respectively. No marked changes were 
noted for the other organs evaluated. Dermal exposure to NBBS altered blood lymphocyte 
count with an elevation of 18, 17, and 19%, respectively, for increasing concentrations of 
NBBS compared with control, resulting in a dose-dependent rise, although statistical 
significance was not obtained. Exposure to NBBS did not markedly alter any other of the 
analyzed hematological parameters (Table 2). Flow cytometric analysis of the DLN did not 
result in significant alterations in numbers and frequency for any of the lymphocyte markers 
and subpopulations examined (Table 3). Due to a technical issue, evaluation of the splenic 
immune markers could not be conducted. There was no difference in spleen cellularity 
following exposure (data not shown).
Dermal Exposure to NBBS Did Not Suppress the IgM Response to SRBC
To evaluate immune suppressive potential, the murine splenic IgM response to SRBC was 
examined in female B6C3F1 mice following a 28-d exposure to NBBS. While suppression 
of IgM response to SRBC was not observed, mice exposed to the lowest concentration of 
NBBS (25%) demonstrated a significant increase of PFC/spleen, (87% compared with 
vehicle-treated mice), suggesting an elevation in IgM antibody response to SRBC (Figure 
3B). In addition, although it did not reach significance, there was a numerical rise in 
PFC/106 cells following exposure to the lowest concentration of NBBS. Mice exposed to the 
positive control, cyclophosphamide (CP), showed a significantly reduced specific spleen 
IgM response and total IgM response compared to vehicle control. No marked changes in 
body weight were observed for these animals.
Discussion
According to the CDC, more than 13 million workers in the United States are exposed to 
chemicals that can be introduced through the skin. Occupations and applications with the 
highest risks for dermal chemical exposure include chemical, pharmaceutical, and plastic/
rubber industries, paint and adhesive applications, and some synthesis intermediates 
products. Occupational skin exposures may result in numerous diseases, which adversely 
affect an individual's health and capacity to perform at work, resulting in significant 
economic losses, including decreased productivity, medical expenses, and loss of work 
because of illness, with associated costs estimated to exceed $1 billion annually in the 
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United States alone (Cashman et al. 2012; Mancini et al. 2008). Dermal exposure to 
hazardous agents may lead to a variety of occupational diseases, including skin diseases 
such as irritant and allergic dermatitis, as well as systemic toxic effects on the body. In 
certain instances dermal exposure is the principal route of exposure, especially for chemicals 
that are relatively nonvolatile. For example, studies of workers in the rubber industry 
suggested that exposure to genotoxic chemicals present in the workplace is greater via skin 
than via lung. Vermeulen at al. (2003) evaluated the potential influence of skin aberrations, 
such as hand dermatitis and traumata of the skin, and acetylation status on urinary 
mutagenicity levels, in relation to inhalation and dermal exposure. It was noted (based on 
the levels of genotoxic compounds found in urine of rubber workers) that skin might be the 
primary route of exposure. It is important to note that while the mice in these investigations 
were exposed to relatively high (25–100%) concentrations of NBBS, these studies were 
conducted for the purpose of hazard identification. However, while actual human exposure 
assessment has not been conducted, it is expected that exposure to the neat form of this 
chemical may occur occupationally.
Despite the high potential for occupational exposure to NBBS (2010b), there are many gaps 
in the characterization of the human risk resulting from exposure to this substance, starting 
with exposure and absorption assessment. Occupational Safety and Health Administration 
Permissible Exposure Limit (PEL) and American Conference of Governmental Industrial 
Hygienists (ACGIH) Threshold Limit Value (TLV) values are not available for this 
chemical. A common indicator of dermal absorption potential is the relative solubility of a 
material in octanol and water (octanol– water partition coefficient, Kow), expressed in the 
logarithmic form as log Kow. NBBS has a log Kow of 2.1 (Proviron Fine Chemicals 2003), 
which suggests significant skin penetration; however, investigations addressing the toxicity 
and immunotoxicity of this chemical following dermal exposures are lacking.
In an attempt to fill some of the data gaps associated with NBBS-related health effects, this 
study was performed to investigate potential immunomodulatory effects of NBBS after a 28-
d dermal exposure in a murine model. Irritancy and sensitization potential were evaluated 
using a combined LLNA. The murine LLNA is considered the gold standard for assessing 
human skin sensitization potential by various regulatory authorities (Cockshott et al 2006). It 
is based upon the concept that chemical sensitizers induce a primary proliferation (induction 
phase) of lymphocytes, through previous stimulation of keratinocytes and Langerhans cells, 
in the lymph nodes draining the site of chemical application, which may be quantified using 
measurement of radiolabeled thymidine incorporation into lymphnode cellular DNA. 
However, based on the findings from our study, NBBS did not induce lymphocyte 
proliferation and is therefore not considered to be a dermal irritant or sensitizer.
NBBS was also evaluated for immunosuppression in a murine model by examining the 
antibody plaque-forming cell (PFC) response to sheep red blood cells (SRBC). This assay 
was reported to be one of the best predictors of immunotoxicity in mice, and one of the most 
sensitive endpoints available to assess chemical induced alteration to the immune system 
(Luster et al. 1988). The PFC assay quantifies production of specific antibody through 
enumeration of antibody-producing cells following immunization with SRBC. It is based 
upon the antibody response to SRBC, a T-dependent antigen that requires functional 
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integration of several cell populations including macrophages, T-helper cells, and B cells 
(Luster et al. 1988). Alterations in function or numbers of any of these populations may 
result in a suppressed immune response to pathogens. Interestingly, while suppression of the 
immune response was not observed in the present study, data demonstrated that the lower 
concentration of NBBS (25% in acetone) induced a significant increase in the IgM response 
in the spleen. However the biological significance of this finding is questionable due to the 
lack of change in spleen cellularity and absence of dose response.
In vitro metabolism studies demonstrated that NBBS was metabolized to 2-hydroxy-NBBS 
through a proposed cytochrome P-450 mechanism (U.S. EPA 2010a). Distribution 
investigations conducted in rats showed that NBBS (1 mg/kg) rapidly enters the brain, 
cerebrospinal fluid, and blood within 1 min post intravenous (iv) injection and is present in 
all tissues and organs examined, including liver, skeletal muscle, kidneys, and fat, by 24 h 
postexposure (Kumar et al. 2007). Toxicokinetic studies on female rats dosed with stable 
isotope labeled NBBS by iv injection estimated that 1 min after administration, liver and 
kidney together received 15% of the dose, blood carried 9%, and muscle accounted for 52% 
of the dose (Kumar et al. 2007). In the present investigation, while no marked changes were 
observed in the immune assays, significant increases in liver and kidney weights were 
observed following exposure in the absence of alterations in spleen, thymus. and body 
weight. In support of our findings, previous studies reported abnormal histology following 
NBBS (U.S. EPA 2010a). Rats dosed via gavage for 28 d at 0, 50, 150, or 1000 mg/kg of 
NBBS displayed enlarged liver and kidneys in animals in the high-exposure group. In 
addition, the histopathology confirmed for all concentrations centrilobular hypertrophy of 
hepatocytes, multifocal necrosis in the liver, and hyaline droplet formation in duct 
epithelium of renal papilla in most animals (U.S. EPA 2010a). Amacher et al. (1998) 
reported that a 10–50% rise in liver weight (similar to the increases observed in our study) is 
a typical response to xenobiotic exposure due to hepatic enzyme induction as a result of 
elevation in workload demand to initiate metabolic clearance. While increased metabolic 
activity supporting a potential hepatotoxic and nephrotoxic role for NBBS is suggested by 
these studies, specific pathways and functional capacity were not evaluated; therefore, 
additional studies are necessary to fully understand this finding.
While dermal exposure to NBBS did not induce marked hematological alterations in the 
present study, other investigations reported such changes. For example, rats orally gavaged 
with NBBS (150 mg/kg) for 28 d showed a decrease in erythrocyte count and hemoglobin 
(U.S. EPA 2010a). In a single-dose threshold study, NBBS produced a dose- and time-
dependent suppression of erythropoiesis when administered by a variety of routes to adult 
guinea pigs and rats when exposed to NBBS by aerosol inhalation, topical application to 
skin and mucous membranes, and gavage (U.S. EPA 2010a). Acute toxicity occurred at 
NBBS exposures of 3 mg/m2 body surface area, and consisted of decreased reticulocyte 
counts, histological changes suggestive of altered vascular permeability, and death. With a 
single dose of 1.5 mg/m2, leukopenia (in guinea pigs), transient increased capillary 
permeability, and reduced hemoglobin (after 1 mo) developed (U.S. EPA 2010a). A 
potential explanation for the differences in these findings may be different duration and 
route of exposure, different models and species, and different exposure concentration. While 
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our study did not show marked alterations in red blood cells, a dose-dependent increase in 
lymphocytes was observed following hematological analysis.
These are the first studies addressing the immunotoxicity and allergic potential induced by 
topical application of NBBS in a murine model. While these findings do not suggest that 
dermal exposure to NBBS produces immunotoxic effects, these observations raise concern 
regarding potential liver and kidney toxicity following exposure to this chemical.
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Figure 1. 
Chemical structure of NBBS.
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Figure 2. 
Irritancy and allergic sensitization potential after dermal exposure to NBBS. Analysis of 
irritancy (A) and the allergic sensitization potential (B) of NBBS using the LLNA. DPM 
represents [3H]thymidine incorporation into draining lymph node cells of BALB/c mice 
following exposure to vehicle or concentration of NBBS (25–100%). SI value is the 
stimulation index (fold change over vehicle control). Bars represent mean (± SE) of five 
mice per group.
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Figure 3. 
NBBS does not suppress the spleen IgM response to SRBC. Analysis of antibody producing 
cells following a 28-d dermal exposure to NBBS (25-100%). The (A) specific and (B) total 
activity IgM response to SRBC was evaluated in the spleen. Bars represent mean fold 
change (± SE) of six mice per group. Cyclophosphamide (CP) was included as the positive 
control. Significance is indicated as *p < .05.
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Table 1
Body/Organ Weights of Female B6C3F1 Mice Dermally Exposed to NBBS for 28 d
Parameter
NBBS (w/v)
0% 25% 50% 100%
Body weight (g) 19.31 ± 0.67 20.43 ± 0.83 20.56 ± 0.74 19.91 ± 0.30
Kidney weight
 (mg) 243 ± 6 302 ± 14** 312 ± 15** 312 ± 12**##
 % bw 1.27 ± 0.02 1.48 ± 0.03** 1.51 ± 0.03** 1.57 ± 0.05**#
Spleen weight
 (mg) 69 ± 2 98 ± 22 74 ± 3 69 ± 4
 % bw 0.36 ± 0.01 0.48 ± 0.11 0.36 ± 0.02 0.35 ± 0.01
Thymus weight
 (mg) 43 ± 4 37 ± 6 46 ± 3 49 ± 4
 % bw 0.23 ± 0.02 0.21 ± 0.01 0.22 ± 0.01 0.24 ± 0.01
Liver weight
 (mg) 901 ± 30** 1226 ± 57*** 1439 ± 41** 1479 ± 44**##
 % bw 4.67 ± 0.10 6.01 ± 0.17*** 7.01 ± 0.11** 7.42 ± 0.16**#
Note. Values are expressed as means (± SE) for each group; bw, body weight. Significantly different from acetone controls at
**
p < .05 or
***
p < .01. Linear trend:
#
p < .001,
##
p < .05.
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Table 2
Hematology Parameters of Female B6C3F1 Mice Dermally Exposed to NBBS for 28 d
Parameter
NBBS
0% 25% 50% 100%
Hemoglobin (g/dl) 12.42 ± 2.04 14.06 ± 0.56 12.80 ± 1.72 14.30 ± 0.29
Erythrocytes (M/μl) 7.460 ± 1.27 8.454 ± 0.33 7.712 ± 1.04 8.520 ± 0.19
Platelets (K/μl) 312 ± 130.5 383 ± 131.2 458 ± 150.2 409.2 ± 119.7
Hematocrit (%) 40.50 ± 7.03 46.74 ± 1.85 42.12 ± 5.75 47.66 ± 1.36
MCV (fl) 53.96 ± 0.54 55.30 ± 0.15 54.54 ± 0.25 55.90 ± 0.72
MCH (pg) 16.84 ± 0.38 16.64 ± 0.28 16.60 ± 0.17 16.78 ± 0.31
MCHC (g/dl) 31.28 ± 0.93 30.10 ± 0.46 30.48 ± 0.27 30.04 ± 0.44
PDW (%) 24.64 ± 1.75 21.80 ± 0.64 22.26 ± 0.74 23.82 ± 1.43
Leukocytes (K/μl) 4.256 ± 1.07 3.704 ± 0.84 3.552 ± 0.83 3.792 ± 0.77
Percent lymphocytes 63.16 ± 4.61 74.38 ± 2.36 74.21 ± 1.43 74.85 ± 0.90#
Percent neutrophils 24.28 ± 2.61 18.77 ± 2.28 18.39 ± 1.30 18.00 ± 0.69
Percent monocytes 6.43 ± 1.01 4.29 ± 0.48 4.118 ± 0.78 4.36 ± 0.88
Percent eosinophils 4.806 ± 1.15 2.064 ± 1.21 2.504 ± 1.17 2.228 ± 0.78
Percent basophils 1.314 ± 0.39 0.494 ± 0.24 0.784 ± 0.32 0.548 ± 0.17
Note. MCH, mean corpuscular hemoglobin; MCV, mean corpuscular volume; PDW, platelet distribution width; MCHC, mean corpuscular 
hemoglobin concentration. Values are expressed as the means (± SE) for each group. Linear trend:
#
p < .05.
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Table 3
Effects of Dermal Exposure to NBBS for 28 d on Draining Lymph Nodes Cell Number 
and of Lymphocyte Subpopulations in Female B6C3F1 Mice
Parameter
NBBS
0% 25% 50% 100%
DLN, number (× 106) 2.176 ± 0.29 3.404 ± 0.45 3.120 ± 0.34 3.411 ± 0.69
B cells, number
 (× 105) 4.6 ± 0.34 6.3 ± 0.74 5.7 ± 0.84 6.4 ± 1.3
 Percent of dLN 22.10 ± 2.4 18.62 ± 0.92 17.92 ± 1.04 18.66 ± 0.33
Neutrophils
 (number) 566 ± 201 843 ± 180 656 ± 307 581 ± 169
 Percent of dLN 0.02 ± 0.007 0.03 ± 0.005 0.02 ± 0.008 0.02 ± 0.06
CD4+ T cells, number
 (× 106) 1.4 ± 0.37 1.7 ± 0.23 1.6 ± 0.15 1.7 ± 0.37
 Percent of dLN 46.76 ± 2.19 48.54 ± 1.07 51.54 ± 1.31 49.24 ± 0.97
CD8+ T cells
 (× 106) 0.67 ± 0.10 1.084 ± 0.14 0.91 ± 0.09 1.025 ± 0.18
 Percent of dLN 29.78 ± 0.77 31.84 ± 0.45 29.50 ± 0.57 30.54 ± 0.73
Dendritic cells
 (number) 8456 ± 3810 7760 ± 702 8390 ± 1609 10573 ± 3023
 Percent of dLN 0.23 ± 0.03 0.24 ± 0.03 0.26 ± 0.03 0.29 ± 0.04
NK cells
 (× 104) 2.8 ± 0.1 2.8 ± 0.3 2.6 ± 0.3 2.7 ± 0.4
 Percent of dLN 0.81 ± 0.06 0.85 ± 0.06 0.85 ± 0.10 0.83 ± 0.07
Note. Mice were dermally exposed to vehicle (acetone) or different concentrations of NBBS for 28 d. The mice were euthanized 24 h after the final 
exposure, DLN were removed, and total cells counted. Numbers and frequency of B and T cells, and subsets of T-cells (CD4+ and CD8+), natural 
killer (NK), and dendritic cells were enumerated. Values represent the means (± SE) for each group. Significantly different from acetone controls at
*
p < .05.
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